Amanote Research
Register
Sign In
Blood Biomarker Measurement as Disease Target: The Case for Generic Treatment of High Natriuretic Peptide Levels Without a Diagnosis of Heart Failure
Journal of the Royal College of Physicians of Edinburgh, The
- United Kingdom
doi 10.4997/jrcpe.2013.201
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Education
History
Date
June 4, 2013
Authors
AL Clark
Publisher
Royal College of Physicians of Edinburgh
Related search
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
New England Journal of Medicine
Medicine
Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Natriuretic Peptide Testing in Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Heart Rate as a Target of Treatment of Chronic Heart Failure
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Usefulness of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide as Biomarkers for Heart Failure in Young Children With Single Ventricle Congenital Heart Disease
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Chronic Heart Failure as a State of Reduced Effectiveness of the Natriuretic Peptide System: Implications for Therapy
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Heat Shock Protein 70 Acts as a Potential Biomarker for Early Diagnosis of Heart Failure
PLoS ONE
Multidisciplinary
Association of B-Type Natriuretic Peptide Levels With Estimated Glomerular Filtration Rate and Congestive Heart Failure
Clinical Medicine and Research
Medicine
Home Care
Community
MicroRNA 210 as a Biomarker for Congestive Heart Failure
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
